Serum bFGF and VEGF correlate respectively with bowel wall thickness and intramural blood flow in Crohn's disease

Inflammatory Bowel Diseases

Volumn 10, Issue 5, 2004, Pages 573-577

  Di Sabatino, Antonio ^a   Ciccocioppo, Rachele ^a   Armellini, Elia ^a   Morera, Raffaele ^a   Ricevuti, Laura ^a   Cazzola, Paolo ^a   Fulle, Ilaria ^a   Corazza, Gino Roberto ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

Angiogenesis; bFGF; Crohn's disease; Fibrosis; Ultrasonography; VEGF

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; BIOLOGICAL MARKER; CONTRAST MEDIUM; GALACTOSE; SHU 508; VASCULOTROPIN;

ABDOMINAL RADIOGRAPHY; ADULT; AGE; AGED; ANGIOGENESIS; ARTICLE; BLOOD SAMPLING; BLOOD VESSEL; CLINICAL ARTICLE; COLOR ULTRASOUND FLOWMETRY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORRELATION FUNCTION; CROHN DISEASE; DIAGNOSTIC IMAGING; ECHOGRAPHY; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROGENESIS; GENDER; HUMAN; ILEUM; INTESTINE BLOOD FLOW; INTESTINE FISTULA; INTESTINE WALL; MALE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STATISTICAL SIGNIFICANCE; THICKNESS; VOLUNTEER;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CROHN DISEASE; DIGESTIVE SYSTEM; FEMALE; FIBROBLAST GROWTH FACTOR 2; FIBROSIS; HUMANS; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; REGIONAL BLOOD FLOW; ULTRASONOGRAPHY, DOPPLER, COLOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 4644318578     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1097/00054725-200409000-00011     Document Type: Article

References (37)

1. Rifkin DB, Moscatelli D. Recent developments in the cell biology of basic fibroblast growth factor. J Cell Biol. 1989;106:1-6.
2. Ferrara N. Vascular endothelial growth factor. Eur J Cancer. 1996;32: 2413-2422.
3. Schulze-Osthoff K, Risau W, Vollmer E, et al. In situ detection of basic fibroblast growth factor by highly specific antibodies. Am J Pathol. 1990; 137:85-92.
4. Bousvaros A, Zurakowski D, Fishman SJ, et al. Serum basic fibroblast growth factor in pediatric Crohn's disease. Dig Dis Sci. 1997;42:378-386.
5. Thorn M, Raab Y, Larsson A, et al. Intestinal mucosal secretion of basic fibroblast growth factor in patients with ulcerative colitis. Scand J Gastroenterol. 2000;35:408-412.
6. Kanazawa S, Tsunoda T, Onuma E, et al. VEGF, basic-FGF, and TGF-β in Crohn's disease and ulcerative colitis: a novel mechanism of chronic intestinal inflammation. Am J Gastroenterol. 2001;96:822-828.
7. Griga T, Tromm A, Spranger J, et al. Increased serum levels of vascular endothelial growth factor in patients with inflammatory bowel disease. Scand J Gastroenterol. 1998;33:504-508.
8. Griga T, Voigt E, Gretzer B, et al. Increased production of vascular endothelial growth factor by intestinal mucosa of patients with inflammatory bowel disease. Hepatogastroenterology. 1999;46:920-923.
9. Bousvaros A, Leichtner A, Zurakowski D, et al. Elevated serum vascular endothelial growth factor in children and young adults with Crohn's disease. Dig Dis Sci. 1999;44:424-430.
10. Di Sabatino A, Fulle I, Ciccocioppo R, et al. Doppler enhancement after intravenous Levovist injection in Crohn's disease. Inflamm Bowel Dis. 2002;8:251-257.
11. Best WR, Becktel JM, Singleton JW, et al. Development of a Crohn's disease activity index. Gastroenterology. 1976;70:439-444.
12. Gasche C, Moser G, Turetschek K, et al. Transabdominal bowel sonography for the detection of intestinal complications in Crohn's disease. Gut. 1999;44:112-117.
13. Louis E, Collard A, Oger AF, et al. Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease. Gut. 2001;49:777-782.
14. Corpechot C, Barbu V, Wendum D, et al. Hypoxia-induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis. Hepatology. 2002;35:1010-1021.
15. Ohmori S, Shiraki K, Sugimoto K, et al. High expression of CD-34 positive sinusoidal endothelial cells is a risk factor for hepatocellular carcinoma in patients with HCV-associated chronic liver diseases. Hum Pathol. 2001;32:1363-1370.
16. Kikuchi K, Kubo M, Kadono T, et al. Serum concentrations of vascular endothelial growth factor in collagen diseases. Br J Dermatol. 1998;139: 1049-1051.
17. Koch E, Harlow I, Haines GK, et al. Vascular endothelial growth factor: a cytokine modulating endothelial function in rheumatoid arthritis. J Immunol. 1994;152:4149-4155.
18. Kalluri R, Sukhatme VP. Fibrosis and angiogenesis. Curr Opin Nephrol Hypertens. 2000;9:413-418.
19. Griga T, Gutzeit A, Sommekamp C, et al. Increased production of vascular endothelial growth factor by peripheral blood mononuclear cells in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol. 1999;11:175-179.
20. + monocytes. Dig Dis Sci. 1999; 44:1196-1201.
21. Blomley MJK, Cosgrove DO. Microbubble echo-enhancers: a new direction for ultrasound? Lancet. 1997;349:1855-1856.
22. Goldberg BB, Liu JB, Burns PN, et al. Galactose-based intravenous sonographic contrast agent: experimental studies. J Ultrasound Med. 1993;12: 463-470.
23. Di Sabatino A, Ciccocioppo R, Benazzato L, et al. Infliximab downregulates basic fibroblast growth factor and vascular endothelial growth factor in Crohn's disease patients. Aliment Pharmacol Ther. 2004;19:1-6.
24. Angerson WJ, Allison MC, Baxter JN, et al. Neoterminal ileal blood flow after ileocolonic resection for Crohn's disease. Gut. 1993;34:1531-1534.
25. Lawrance IC, Maxwell L, Doe W. Altered response of intestinal mucosal fibroblasts to profibrogenic cytokines in inflammatory bowel disease. Inflamm Bowel Dis. 2001;7:226-236.
26. Dignass AU, Tsunekawa S, Podolsky DK. Fibroblast growth factors moderate intestinal epithelia] cell growth and migration. Gastroenterology. 1994;106:1254-1262.
27. Di Sabatino A, Ciccocioppo R, Luinetti O, et al. Increased enterocyte apoptosis in inflamed areas of Crohn's disease. Dis Colon Rectum. 2003; 46:1498-1507.
28. Roberts W, Palade G. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci. 1995;108:2369-2379.
29. Ito A, Hirota S, Mizuno H, et al. Expression of vascular permeability factor (VPF/VEGF) messenger RNA by plasma cells: possible involvement in the development of edema in chronic inflammation. Pathol Int. 1995;45:715-720.
30. Appleton I, Brown NJ, Willis D, et al. The role of vascular endothelial growth factor in a murine chronic granulomatous tissue air pouch model of angiogenesis. J Pathol. 1996;180:90-94.
31. Sandborn WJ, Hanauer SB. Infliximab in the treatment of Crohn's disease: a user's guide for clinicians. Am J Gastroenterol. 2002;97:2962-2972.
32. D'Amato RJ, Loughnan MS, Flynn E, et al. Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci U S A. 1994;91:4082-4085.
33. Hulten L, Lindhagen J, Lundgren O, et al. Regional intestinal blood flow in ulcerative colitis and Crohn's disease. Gastroenterology. 1977;72:388-396.
34. Hatoum OA, Binion DG, Otterson ME, et al. Acquired microvascular dysfunction in inflammatory bowel disease: loss of nitric oxide-mediated vasodilation. Gastroenterology. 2003;125:58-69.
35. Bouakaz A, Krenning BJ, Vletter WB, et al. Contrast superharmonic imaging: a feasibility study. Ultrasound Med Biol. 2003;29:547-553.
36. Schneider M. SonoVue, a new ultrasound contrast agent. Eur Radiol. 1999;9(Suppl 3):S347-S348.
37. Kornbluth A, Salomon P, Sachar DB. Crohn's disease. In: Sleisenger MH, Fordtran JS, eds. Gastrointestinal disease: pathophysiology, diagnosis and management. 5th ed. Philadelphia, PA: WB Saunders, 1993:1270-1304.